Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS
Consultant Physician
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, FCPS Gastroenterology, MRCP (UK), MRCPE (UK), MACG (USA)
Internal Medicine Specialist
MBBS, FCPS Gastroenterology, MRCP (UK), MRCPE (UK), MACG (USA)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
General Physician
MBBS, MRCP (Medicine) UK, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), M.R.C.P-I (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures